216
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Neuroprotective potential of ketamine prevents developing brain structure impairment and alteration of neurocognitive function induced via isoflurane through the PI3K/AKT/GSK-3β pathway

, , , &
Pages 501-512 | Published online: 04 Feb 2019

References

  • Sanabria-CastroAAlvarado-EcheverríaIMonge-BonillaCMolecular pathogenesis of Alzheimer’s disease: an updateAnn Neurosci2017241465428588356
  • MattsonMPPartinJBegleyJGAmyloid beta-peptide induces apoptosis-related events in synapses and dendritesBrain Res19988071–21671769757026
  • Rubio-PerezJMMorillas-RuizJMA review: inflammatory process in Alzheimer’s disease, role of cytokinesScientific World Journal2012756357
  • DanieleSGBéraudDDavenportCChengKYinHMaguire-ZeissKAActivation of MyD88-dependent TLR1/2 signaling by mis-folded α-synuclein, a protein linked to neurodegenerative disordersSci Signal20158376ra4525969543
  • HaSKMoonEJuMSKimDHRyuJHOhMSKimSY6-Shogaol, a ginger product, modulates neuroinflammation: a new approach to neuroprotectionNeuropharmacology201263221122322465818
  • GonzálezHElguetaDMontoyaAPachecoRNeuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseasesJ Neuroimmunol20142741–211325091432
  • DobosNKorfJLuitenPGEiselULNeuroinflammation in Alzheimer’s disease and major depressionBiol Psychiatry201067650350420185031
  • BajTSethRRole of curcumin in regulation of TNF-α mediated brain inflammatory responsesRecent Pat Inflamm Allergy Drug Discov2018121697729972106
  • SinghalGJaehneEJCorriganFTobenCBauneBTInflammasomes in neuroinflammation and changes in brain function: a focused reviewFront Neurosci2014831525339862
  • CaoXZMaHWangJKPostoperative cognitive deficits and neuroinflammation in the hippocampus triggered by surgical trauma are exacerbated in aged ratsProg Neuropsychopharmacol Biol Psychiatry20103481426143220691747
  • MoreSVKumarHKimISSongS-YChoiD-KCellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson’s diseaseMediators Inflamm2013201395237523935251
  • MeijerLFlajoletMGreengardPPharmacological inhibitors of glycogen synthase kinase 3Trends Pharmacol Sci200425947148015559249
  • YaoHBShawPCWongCCWanDCExpression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brainJ Chem Neuroanat200223429129712048112
  • Azoulay-AlfaguterIYaffeYLicht-MuravaADistinct molecular regulation of glycogen synthase kinase-3alpha isozyme controlled by its N-terminal region: functional role in calcium/calpain signalingJ Biol Chem201128615134701348021266584
  • LiDWLiuZQChenWYaoMLiGRAssociation of glycogen synthase kinase-3β with Parkinson’s disease (review)Mol Med Rep2014962043205024681994
  • ShihRHWangCYYangCMNF-kappaB signaling pathways in neurological inflammation: a mini reviewFront Mol Neurosci201587726733801
  • MazoitJXDalensBJPharmacokinetics of local anaesthetics in infants and childrenClin Pharmacokinet2004431173214715049
  • AurielERegevKKorczynADNonsteroidal anti-inflammatory drugs exposure and the central nervous systemHandb Clin Neurol201411957758424365321
  • GaoMRejaeiDLiuHKetamine use in current clinical practiceActa Pharmacol Sin201637786587227018176
  • SchmidtMSachseCRichterWXuCFändrichMGrigorieffNComparison of Alzheimer Abeta(1-40) and Abeta(1-42) amyloid fibrils reveals similar protofilament structuresProc Natl Acad Sci U S A200910647198131981819843697
  • BhattPCPathakSKumarVPandaBPAttenuation of neurobehavioral and neurochemical abnormalities in animal model of cognitive deficits of Alzheimer’s disease by fermented soybean nanonutraceuticalInflammopharmacology201826110511828791538
  • ZhangJDongYXuZ2-Deoxy-D-glucose attenuates isoflurane-induced cytotoxicity in an in vitro cell culture model of H4 human neuroglioma cellsAnesth Analg201111361468147521965367
  • FallsNSinghDAnwarFVermaAKumarVAmelioration of neurodegeneration and cognitive impairment by lemon oil in experimental model of stressed miceBiomed Pharmacother201810657558329990845
  • NewmanJPKossonDSPassive avoidance learning in psychopathic and nonpsychopathic offendersJ Abnorm Psychol19869532522563745647
  • WeydertCJCullenJJMeasurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissueNat Protoc201051516620057381
  • HaringMOffermannSDankerTHorstIPeterhanselCStamMChromatin immunoprecipitation: optimization, quantitative analysis and data normalizationPlant Methods200731117892552
  • Ramos Bernardes da Silva FilhoSOliveira BarbosaJHRondinoniCNeuro-degeneration profile of Alzheimer’s patients: a brain morphometry studyNeuroimage Clin201715152428459000
  • SalekRMXiaJInnesAA metabolomic study of the CRND8 transgenic mouse model of Alzheimer’s diseaseNeurochem Int201056893794720398713
  • RudnitskayaEAMuralevaNAMaksimovaKYKiselevaEKolosovaNGStefanovaNAMelatonin attenuates memory impairment, amyloid-β accumulation, and neurodegeneration in a rat model of sporadic Alzheimer’s diseaseJ Alzheimers Dis201547110311626402759
  • MaccioniRBRojoLEFernándezJAKuljisROThe role of neuro-immunomodulation in Alzheimer’s diseaseAnn N Y Acad Sci2009115324024619236346
  • TanseyMGGoldbergMSNeuroinflammation in Parkinson’s disease: its role in neuronal death and implications for therapeutic interventionNeurobiol Dis201037351051819913097
  • HsiaoHYChenYCChenHMTuPHChernYA critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington’s diseaseHum Mol Genet20132291826184223372043
  • PrinceMBryceRAlbaneseEWimoARibeiroWFerriCPThe global prevalence of dementia: a systematic review and metaanalysisAlzheimers Dement201391637523305823
  • PrinceMComas-HerreraAKnappMGuerchetMKaragiannidouMWorld Alzheimer Report 2016: Improving Healthcare for People Living with Dementia. Coverage, Quality and Costs now and in the Future Commissioned Report by King’s College, London, UKLondonAlzheimer’s Disease International2016131
  • JavierFCobosMdel MarMMA review of psychological intervention in Alzheimer’s diseaseInt J Psychol Psychol Ther2012123373388
  • IvanovAVBartoschBIsaguliantsMGOxidative stress in infection and consequent diseaseOxid Med Cell Longev20172017349604328255425
  • CastilloWOAristizabal-PachonAFGalantamine protects against beta amyloid peptide-induced DNA damage in a model for Alzheimer’s diseaseNeural Regen Res201712691691728761423
  • DinizBSTeixeiraALBrain-derived neurotrophic factor and Alzheimer’s disease: physiopathology and beyondNeuromolecular Med201113421722221898045
  • FumagalliFRacagniGRivaMAThe expanding role of BDNF: a therapeutic target for Alzheimer’s disease?Pharmacogenomics J20066181516314887
  • JebelliJDPiersTMAmyloid-β oligomers unveil a novel primate model of sporadic Alzheimer’s diseaseFront Neurosci201594725852450
  • PisoschiAMPopAThe role of antioxidants in the chemistry of oxidative stress: a reviewEur J Med Chem201597557425942353
  • StenvinkelPKettelerMJohnsonRJIL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia – the good, the bad, and the uglyKidney Int20056741216123315780075
  • O’ConnorJJNeuroimmunology and synaptic functionNeuropharmacology201596Pt A1225804505
  • LudwigAMechanisms of KCC2 Upregulation during DevelopmentdissertationHelsinkiUniversity of Helsinki2008
  • ChenJThe cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression cold spring harb perspect med201663a02610426931810
  • NotebornMHChicken anemia virus induced apoptosis: underlying molecular mechanismsVet Microbiol2004982899414741120
  • ChangWLChapkinRSLuptonJRFish oil blocks azoxymethane-induced rat colon tumorigenesis by increasing cell differentiation and apoptosis rather than decreasing cell proliferationJ Nutr199812834914979482754
  • Rodríguez-FeoJAFortesJAceitunoEDoxazosin modifies Bcl-2 and Bax protein expression in the left ventricle of spontaneously hypertensive ratsJ Hypertens200018330731510726718
  • ParaisoKHTVan Der KooiKMessinaJLSmalleyKSMMeasurement of constitutive MAPK and PI3K/AKT signaling activity in human cancer cell linesMethods Enzymol201048454956721036250
  • PortaCPaglinoCMoscaATargeting PI3K/Akt/mTOR signaling in cancerFront Oncol201446424782981
  • ZhangYZhangZWangHNeuroprotective effect of ginsenoside Rg1 prevents cognitive impairment induced by isoflurane anesthesia in aged rats via antioxidant, anti-inflammatory and anti-apoptotic effects mediated by the PI3K/AKT/GSK-3β pathwayMol Med Rep20161432778278427485139
  • SpokoiniRKfir-ErenfeldSYefenofESionovRVGlycogen synthase kinase-3 plays a central role in mediating glucocorticoid-induced apoptosisMol Endocrinol20102461136115020371704
  • AltmanFPStudies on the reduction of tetrazodium salts – III. The products of chemical and enzymic reductionHistochemistry19743821551714361038
  • ZhangXJiangDJiangWZhaoMGanJRole of TLR4-Mediated PI3K/AKT/GSK-3β signaling pathway in apoptosis of rat hepatocytesBiomed Res Int2015201563132626770978
  • KennawayNGCarrero-ValenzuelaRDEwartGIsoforms of mammalian cytochrome c oxidase: correlation with human cytochrome c oxidase deficiencyPediatr Res19902855295352175025